期刊文献+

比较雷米普利与卡托普利对糖尿病大鼠心肌间质重构的影响 被引量:3

To Investigate the Protection of Captopril and Ramipril on the Interstitium of Diabetic Cardiomyopathy
下载PDF
导出
摘要 目的:通过观察雷米普利与卡托普利对糖尿病大鼠心脏指数、心肌局部血管紧张素Ⅱ(AngⅡ)、Caspase-3蛋白阳性染色指数、心肌细胞凋亡指数(AI)的影响,探讨两者对糖尿病大鼠心肌病的可能保护机制。方法:40只健康雄性SD大鼠随机分为10只正常对照组和30只糖尿病组,糖尿病组用链脲佐菌素(STZ)注射建模,成功后随机分为糖尿病未治疗组(糖尿病对照组)、雷米普利治疗组和卡托普利治疗组,每组10只。治疗组按药品说明书的推荐以雷米普利2.5mg/(kg.d)水溶液灌胃,卡托普利50mg/(kg.d)水溶液灌胃,正常对照组和糖尿病对照组每天以同等体积生理盐水灌胃。给药9周后,麻醉处死动物,放射免疫法测定心肌局部AngⅡ的含量,ABC免疫组化法检测Caspase-3蛋白阳性染色指数,免疫组化法检测Ⅰ、Ⅲ型胶原的含量。结果:与正常对照组相比,糖尿病对照组与治疗组心脏指数均增大(P<0.05),AngⅡ含量显著升高(P<0.05),心肌细胞凋亡指数(AI)明显增高(P<0.05),Caspase-3蛋白阳性染色指数也增高(P<0.05);用雷米普利和卡托普利治疗后,上述指标均有显著改善,雷米普利组较卡托普利组心脏指数、Ⅰ、Ⅲ型胶原含量改善不明显(P<0.05),其余指标两组比较没有统计学差别(P>0.05)。结论:糖尿病心肌病中心肌间质有重构现象发生,雷米普利与卡托普利均可以通过降低AngⅡ、Caspase-3阳性蛋白指数来改善心脏的功能,而且两组相比稍有差别。 Objective. To study the possible protection mechanism through the effect of Captopril and Ramipril on the diabetic rats cardiac index, the expression of Ang Ⅱ , AI,Caspase-3. Methods: 36 male SD rats were randomly put in to 2 groups , 9 as normal control group and the other 27 as diabetic group which was induced by STZ, after the model was constructed successfully , again randomly devided in to diabetic control group, Captopril treatedgroup and ramipril treated group,each contains 9. Captopril was administra- l^ed at the dose of 50mg/kg once a day, Ramipril was administrated at the dose of 2. 5mg/kg once a day-while in the diabetic control group and the normal control the same volume sodium chloride was administrated, nine weeks later , all rats were executed in the condition of anaesthesia, Radioimmunity was used to measure the expression of Ang Ⅱ, ABC immunohistochemical staining was used respectively to detect the changes of apoptosis and protein expression of Caspase-3 , immunohistochemistry was used to measure expression levels of type Ⅰ collagen, type Ⅲ collagen. Results. Compared to the normal control , the cardiac index,the content of AngⅡ ,AI and the protein expression of Caspase-3 significantly increased (P〈0.05) ;after treated by Captopril and Ramipril, the above was all improved, but cardiac index was significantly higher in the Captopril treated group (P〈0. 05),others were not different in two groups . Conclusion: The remodeling of Interstitium took place in the diabetic cardiomyopathy ,Captopril and ramipril could improve the function of heart by the means of decreasing the content of Ang Ⅱ , AI and protein expression of Caspase-3, there was less difference in the two groups.
出处 《数理医药学杂志》 2009年第2期174-176,共3页 Journal of Mathematical Medicine
关键词 糖尿病心肌病 间质重构 雷米普利 卡托普利 AngⅡ Caspase-3 diabetic cardiomyopathy interstitium remodeling captopril ramipril AngⅡ Caspase-3
  • 相关文献

参考文献6

二级参考文献29

  • 1Philipp-Staheli J, Payne SR , Kemp CJ. p27(Kipl): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res ,2001,264(1): 148 - 168.
  • 2Wolf G, Wenzal UO. Angiotensin Ⅱ and cell cycle regulation.Hypertension, 2004, 43 (4) : 693 - 698.
  • 3Rao GN. Differential regulation of p27kipl levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells. Biochimica et Biochimica Acta(BBA), 1999 , 1448(3): 525 -532.
  • 4Diep QN, El Mabrouk M. Expression of cell cycle proteins in blood vessels of angiotensin 11-infused rats: role of AT(I) receptors.Hypertension, 2001, 37 (2) : 604 - 608.
  • 5Sadoshima J, izumo S. Molecular characterization of angiotensin Ⅱ-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ Res , 1993(73) : 413 - 423.
  • 6Nielsen LB,Bartels ED,Bollano E.Over expression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice[J].Biol Chem,2002,277(30):27014-27020.
  • 7Giles TD,Ouyang J,kerut EK,et al.Changes in protein kinase C in early cardiomyopathy and in gracilis muscle the BB/W or diabetic rat[J].Am J Physiol,1998,274 (1pt2):H295-307.
  • 8Matsui H,Okumura K,Mukawa H,et al.Increased oxysterol contents in diabetic rat hearts:their involvement in diabetic cardiomyopathy[J].Can J Cardial,1997,13(4):373-379.
  • 9Feng Q,Lambert ML,Callow ID,et al.Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure[J].Clin Pharmacol Ther,2000,67 (3):292-298.
  • 10Ledet T,Vuust J.Arterial procollagen type Ⅰ,and type Ⅲ,and fibronectin:effects of diabetic serum,glucose,insulin,ketone,and growth hormone studied on rabbit aortic myomedial cell cultures[J].Diabetes,1977,26 (8):798-803.

共引文献14

同被引文献42

  • 1赵林双,廖玉华,王敏,周子华,向光大,侯洁,乐岭,孙慧伶.糖尿病心功能不全患者血浆抗AT_1受体自身抗体和AngⅡ检测的临床价值[J].中国微循环,2007,11(1):39-41. 被引量:1
  • 2Takai S, Miyazaki M. The role of chymase in vascular pro- liferation. Drug News Perspect, 2002, 15 . 278 -282.
  • 3Kajstura J, Fiordaliso F, Andreoli AM. IGF-I overexpression inhibits the development of diabetic cardiomyopathy and an- giotensin II mediated oxidative stress. Diabetes,2001, 50 : 1414-1424.
  • 4Ogata T, Miyauchi T, Sakai S ,et al. Stimulation of peroxisome proliferation activated receptora (PPARa) attenuates cardiac fibrosis and endothelin-1 production in pressure over loaded rat hearts. Clin Sci ( Lond), 2002, 103 ( suppl 48 ) : 284 - 288.
  • 5Song Y, Du Y, Prabhu SD, et al. Diabetic cardiomyopathy in OVE26 mice shows mitochondrial ROS production and di- vergence between in vivo and in vitro contractility. Rev Diabe Stud,2007,4 : 159 - 168.
  • 6Zhang GX, Lu XM, Kimura S, et al. Role of mitochondria in angiotensin II-induced reactive oxygen species and mito- gen-activated protein kinase activation. Cardiovasc Res, 2007,76 : 204-212.
  • 7Finckenberg P, inkinen K, Ahonen J, et al. Angiotensin I induces connectivetissue growth factor gene expression via calcineurin-dependent pathways. Am J Patrol, 2003, 163 : 355 - 366.
  • 8Gray MO, Long CS, Kalinyak JE, et al. Angiotensin II stim- ulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res, 1998, 40 : 352 -363.
  • 9Belmadani S, Bemal J, Wei CC,et al. A thrombospondin-1 antagonist of transforming growth factor-13 activation blocks cardiomyopathy in rats with diabetes and elevated angioten I]. Am J Pathol,2007,171 : 777 -789.
  • 10Zhang XM, Shen F, Xu ZY, et al. Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ- induced rats. Int J Cardiol,2005,105 : 192 -197.

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部